Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France

IF 2.9 4区医学 Q2 INFECTIOUS DISEASES Infectious diseases now Pub Date : 2024-02-09 DOI:10.1016/j.idnow.2024.104863

A. Saade , B. Wyplosz , M. Baldeyrou , C. Paris , P. Tattevin , C. Janssen , for the SPILF group “Vaccination et Prévention”

{"title":"Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France","authors":"A. Saade , B. Wyplosz , M. Baldeyrou , C. Paris , P. Tattevin , C. Janssen , for the SPILF group “Vaccination et Prévention”","doi":"10.1016/j.idnow.2024.104863","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.</p></div><div><h3>Methods</h3><p>Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.</p></div><div><h3>Results</h3><p>A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.</p></div><div><h3>Conclusions</h3><p>Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000186/pdfft?md5=74fa29acbe7c3ae2ea217f07b4970822&pid=1-s2.0-S2666991924000186-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases now","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666991924000186","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.

Methods

Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.

Results

A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.

Conclusions

Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

免疫力低下患者的感染预防：对法国现有组织机构的跨横向多中心调查。

目的评估目前全国范围内免疫功能低下患者（ICP）感染预防工作的组织情况：方法：基于 2022 年发布的在线调查，在全国范围内开展横断面多中心研究：共有 341 名医生（96% 为毕业生，32% 为传染病专家）参与调查，中位年龄为 40 [35-51] 岁。30%的受访者表示可在现场获得 ICP 感染预防咨询，29%的受访者表示可在旅行前获得 ICP 专门咨询，16%的受访者表示可在实体器官移植候选者中获得感染预防咨询，6%的受访者表示可在重返工作岗位后获得 ICP 咨询。大多数参与者（73%）了解全国范围内的 ICP 疫苗接种指南，50% 的参与者认为可以放心使用。10%的参与者开发了预防感染建议和 ICP 疫苗接种工具，89%的参与者希望获得他人开发的工具：结论：ICP 的感染预防仍被忽视。涵盖 ICP 预防所有领域的指南将大受欢迎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊